• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG介导的抗体反应抑制并不需要补体激活。

Complement activation is not required for IgG-mediated suppression of the antibody response.

作者信息

Heyman B, Wiersma E, Nose M

机构信息

Department of Immunology, Uppsala University, Sweden.

出版信息

Eur J Immunol. 1988 Nov;18(11):1739-43. doi: 10.1002/eji.1830181113.

DOI:10.1002/eji.1830181113
PMID:3060362
Abstract

Feedback suppression of the antibody response by IgG is known to be dependent on intact Fc regions. However, it is not clear which of the Fc-mediated effector functions is required. In the present report we have studied whether ability or inability of the IgG antibodies to activate the complement system was of consequence for their immunosuppressive effect. First, a monoclonal IgG1-anti-2,4,6-trinitrophenyl (TNP) antibody, unable to activate complement via the classical or alternate pathway, was shown to be able to inhibit more than 90% of the in vivo sheep erythrocyte-specific antibody response in mice when TNP coupled to sheep erythrocytes was used as antigen. Second, we investigated the immunosuppressive ability of a non-complement-activating mutant IgG2a-anti-TNP monoclonal antibody. The mutant differs from the wild type by a single amino acid substitution in the CH2 domain leading to inability to fix complement factor C1q. However, the mutant has the same affinity for antigen and the same Fc receptor-binding capacity as the wild type antibody. It is demonstrated that the mutant was as efficient as the wild type antibody in inhibiting an in vitro antibody response to TNP-coupled sheep erythrocytes. These findings confirm the non-determinant specificity and Fc dependence of IgG-mediated suppression, and show that the Fc-mediated effector mechanism is independent of complement activation. The results instead suggest binding to Fc receptors as a necessary step in feedback immunosuppression and favor inactivation of B cells by cross-linking of Fc and antigen receptors on their surface rather than elimination of antigen by complement-dependent phagocytosis as the effector mechanism.

摘要

已知IgG对抗体反应的反馈抑制依赖于完整的Fc区域。然而,尚不清楚需要哪种Fc介导的效应功能。在本报告中,我们研究了IgG抗体激活补体系统的能力与否对其免疫抑制作用是否有影响。首先,当将与绵羊红细胞偶联的三硝基苯(TNP)用作抗原时,一种无法通过经典或替代途径激活补体的单克隆IgG1-抗-2,4,6-三硝基苯(TNP)抗体,被证明能够抑制小鼠体内超过90%的绵羊红细胞特异性抗体反应。其次,我们研究了一种非补体激活突变体IgG2a-抗-TNP单克隆抗体的免疫抑制能力。该突变体与野生型的区别在于CH2结构域中的单个氨基酸取代,导致无法固定补体因子C1q。然而,该突变体与野生型抗体具有相同的抗原亲和力和相同的Fc受体结合能力。结果表明,该突变体在抑制对TNP偶联的绵羊红细胞的体外抗体反应方面与野生型抗体一样有效。这些发现证实了IgG介导的抑制的非决定性特异性和Fc依赖性,并表明Fc介导的效应机制独立于补体激活。相反,结果表明与Fc受体结合是反馈免疫抑制的必要步骤,并且支持通过表面Fc和抗原受体的交联使B细胞失活,而不是通过补体依赖性吞噬作用消除抗原作为效应机制。

相似文献

1
Complement activation is not required for IgG-mediated suppression of the antibody response.IgG介导的抗体反应抑制并不需要补体激活。
Eur J Immunol. 1988 Nov;18(11):1739-43. doi: 10.1002/eji.1830181113.
2
Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.与三硝基苯(TNP)偶联细胞结合的小鼠单克隆杂交IgG1-2a单价抗TNP抗体激活人经典补体途径。
J Immunol. 1985 Jan;134(1):486-91.
3
Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.人IgA抗体及其Fabα片段的抗炎活性:对IgG介导的补体激活的抑制作用
Eur J Immunol. 1989 Dec;19(12):2243-9. doi: 10.1002/eji.1830191210.
4
Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.小鼠IgG2a与同种型特异性自身抗体形成的免疫复合物对效应器功能的激活作用。
Immunology. 1995 Apr;84(4):645-52.
5
Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact?Fc 依赖性 IgG 介导的抗体应答抑制:事实还是假象?
Scand J Immunol. 1990 May;31(5):601-7. doi: 10.1111/j.1365-3083.1990.tb02811.x.
6
Factors influencing the endocytosis of immune complexes.影响免疫复合物内吞作用的因素。
Adv Nephrol Necker Hosp. 1984;13:341-67.
7
Characterization of C1q by monoclonal antibodies.用单克隆抗体对C1q进行表征。
Behring Inst Mitt. 1984 Nov(76):42-58.
8
Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.IgG2b上的碳水化合物链:有效反馈免疫抑制的必要条件。
J Immunol. 1985 Jun;134(6):4018-23.
9
IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.在缺乏Fc受体γ链的小鼠中,IgG介导的抗体反应增强作用较弱,而在缺乏FcγRII的小鼠中这种作用增强。
J Immunol. 1999 Jul 15;163(2):618-22.
10
Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype.单克隆绵羊红细胞特异性IgG抗体的免疫调节:抑制作用与抗原结合水平相关,而非与同种型相关。
J Immunol. 1984 Mar;132(3):1136-43.

引用本文的文献

1
Dynamics of antibody engagement of red blood cells and .红细胞抗体结合的动力学及…… (原文似乎不完整)
Front Immunol. 2024 Nov 28;15:1475470. doi: 10.3389/fimmu.2024.1475470. eCollection 2024.
2
Antibody feedback regulation.抗体反馈调节
Immunol Rev. 2024 Nov;328(1):126-142. doi: 10.1111/imr.13377. Epub 2024 Aug 23.
3
IgG Suppresses Antibody Responses to Sheep Red Blood Cells in Double Knock-Out Mice Lacking Complement Factor C3 and Activating Fcγ-Receptors.IgG 抑制缺乏补体因子 C3 和激活 Fcγ 受体的双敲除小鼠对绵羊红细胞的抗体反应。
Front Immunol. 2020 Jul 8;11:1404. doi: 10.3389/fimmu.2020.01404. eCollection 2020.
4
The history of IgG glycosylation and where we are now.IgG 糖基化的历史和现状。
Glycobiology. 2020 Mar 20;30(4):202-213. doi: 10.1093/glycob/cwz065.
5
IgG-mediated immune suppression in mice is epitope specific except during high epitope density conditions.除了在高表位密度条件下,IgG 介导的小鼠免疫抑制具有表位特异性。
Sci Rep. 2018 Oct 16;8(1):15292. doi: 10.1038/s41598-018-33087-6.
6
Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking.被动给予特异性IgG对IgG反应的表位特异性抑制:表位掩盖的证据
Front Immunol. 2017 Mar 6;8:238. doi: 10.3389/fimmu.2017.00238. eCollection 2017.
7
IgG Suppresses Antibody Responses in Mice Lacking C1q, C3, Complement Receptors 1 and 2, or IgG Fc-Receptors.IgG抑制缺乏C1q、C3、补体受体1和2或IgG Fc受体的小鼠的抗体反应。
PLoS One. 2015 Nov 30;10(11):e0143841. doi: 10.1371/journal.pone.0143841. eCollection 2015.
8
Immunogenicity of protein therapeutics: The key causes, consequences and challenges.蛋白质治疗药物的免疫原性:关键原因、后果及挑战。
Self Nonself. 2010 Oct;1(4):314-322. doi: 10.4161/self.1.4.13904.
9
Functions of antibodies in the regulation of B cell responses in vivo.抗体在体内调节B细胞反应中的功能。
Springer Semin Immunopathol. 2001 Dec;23(4):421-32. doi: 10.1007/s281-001-8168-4.
10
Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.在缺乏Fcγ受体的小鼠中,高效IgG介导的对初次抗体应答的抑制作用。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2244-9. doi: 10.1073/pnas.96.5.2244.